Developer docs
API playgroundTry for free, no card

Search company profiles

n!Biomachines

Full company profile

uuid002j9ly

Namestring
n!Biomachines
Legal namestring
n!Biomachines Ltd.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

n!Biomachines Ltd. is a Burlington, Ontario-based biotechnology company—wholly owned by German parent The Cultivated B GmbH—that develops and manufactures fit-for-purpose bioreactors under the AUXO V® brand for next-generation bioprocessing. Founded in 2021 and operating with 11–50 employees, the company targets the food, supplement, and cosmetics industries rather than pharmaceutical applications, positioning its hardware as a lower-cost, purpose-built alternative to incumbent pharma-grade systems.

Its product portfolio spans three scale tiers—AUXO V® Benchtop, Pilot-Scale, and Industrial-Scale bioreactors (up to 25,000L)—supported by dedicated software for advanced automation and real-time on-site and remote monitoring. Core differentiators include fit-for-purpose engineering for specific biological processes and host organisms (cell, microbial, algae), modular cultivation design, and a design philosophy that strips 'superfluous features' to reduce capital and operating costs. The AUXO V bioreactor earned a 2024 Red Dot Design Award.

Commercially, n!Biomachines runs a dual go-to-market: a sales-led motion targeting enterprise and industrial buyers through website CTAs ('Configure your biomachine', 'Meet an expert') with multi-year contracts on industrial-scale systems, alongside a product-led/self-service channel for benchtop and pilot customers. Revenue comes from bioreactor hardware sales, customization/configuration, and support services. Recent strategic activity—MOUs with the Weizmann Institute of Science (Nov 2025) and Lambton College (May 2025), and entry into the NVIDIA Connect Program (2025)—signals ecosystem-building around scientific validation and AI-enabled bioprocessing, though no financial scale signals (revenue, funding, headcount growth) are disclosed.

Short descriptiontext

n!Biomachines Ltd., a subsidiary of The Cultivated B GmbH, develops and manufactures fit-for-purpose AUXO V® bioreactors spanning benchtop to industrial scale (up to 25,000L) for the food, supplement, and cosmetics industries, alongside supporting automation and real-time monitoring software.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBurlington, Canada
HQ citystring
Burlington
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioreactor manufacturing, bioprocessing equipment, cellular agriculture systems, precision fermentation bioreactors, industrial-scale bioprocessing
Industry3 codes
PRIMARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Industrial Instruments For Measurement, Display, And Control3823
Product category
Bioprocessing Equipment
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Bioreactor Hardware Sales
TypeHardware Sales
Description

Sale of fit-for-purpose bioreactor systems across benchtop, pilot-scale, and industrial-scale configurations. Hardware includes AUXO V® bioreactors tailored to specific biological processes and customer requirements.

n-factorial.com:443
2Support & Services
TypeProfessional Services
Description

Technical support, maintenance, and services for bioreactor systems including Bioengineering hub services.

n-factorial.com:443
3Customization & Configuration
TypeHardware Sales
Description

Tailored bioreactor solutions engineered to meet specific customer requirements for different types of bioprocesses or host organisms.

n-factorial.com:443
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Industrial-scale bioreactors for large-scale production
ModelOtherBilling cadenceMulti-year contract
Notes

Available upon request; tailored to company needs

n-factorial.com:443
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1AUXO V®
Description

Fit-for-purpose bioreactor product line designed and engineered to meet specific requirements of biological processes for different cell types, hosts, and products. Available in benchtop, pilot-scale, and industrial-scale configurations.

n-factorial.com:443
Core offering1 text field

n!Biomachines develops and manufactures fit-for-purpose AUXO V® bioreactor systems for next-generation bioprocessing, available in benchtop, pilot-scale, and industrial-scale configurations up to 25,000 liters. The company provides proprietary software for advanced automation and real-time monitoring, along with support services and a bioengineering hub, targeting the food, supplement, and cosmetics industries with affordable, scalable, and modular solutions tailored to specific biological processes and host organisms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Scalable production from benchtop to industrial scale up to 25,000L
Product overview1 text field

n!Biomachines is a subsidiary of The Cultivated B that develops and manufactures fit-for-purpose bioreactors under the AUXO V® brand. The product portfolio consists of three core bioreactor lines—Benchtop, Pilot-Scale, and Industrial-Scale—along with supporting software solutions. The AUXO V® bioreactors are designed for specific biological processes and organisms, targeting the food, supplement, and cosmetics industries. The bioreactors offer scalability from laboratory scale up to 25,000L, with features including modularity for different cultivation types (cell, microbial, algae), advanced automation, real-time monitoring, and a focus on affordability and sustainability.

Product and service1 record
1AUXO V® Benchtop Bioreactors
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-03
Description

Entered a Memorandum of Understanding (MOU) to validate and advance the functionality of n!Biomachines' next-generation bioreactor systems. The partnership focuses on scientific validation of bioreactor technology for bioprocessing applications.

2Lambton College
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Signed MOU to advance cellular agriculture innovation in Canada. Partnership marks beginning of collaborative effort to advance the field of cellular agriculture, with n!Biomachines providing bioreactor technology and expertise.

n-factorial.com:443
Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-04-01
Description

n!Biomachines joined the NVIDIA Connect Program as part of their mission to enable smarter biomanufacturing. The partnership represents a significant step forward in AI-enabled bioprocessing capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in bioprocess solutions, including bioreactors for cell culture and microbial fermentation. Directly competes with n!Biomachines in bioprocess equipment, though Sartorius is heavily focused on pharmaceutical applications where n!Biomachines' fit-for-purpose food-grade positioning differentiates.

TypeDirect peer
Description

Specializes in single-use bioreactors for cell therapy, regenerative medicine, and cell culture applications. Direct peer in scalable single-use bioreactor hardware, with comparable modularity and customization features.

TypeDirect peer
Description

Custom-engineered bioreactor and fermentation systems provider serving cell therapy, vaccines, and biotech manufacturing. Direct peer in custom large-scale bioreactor engineering, with growing overlap in cellular agriculture and food-grade bioprocessing.

TypeDirect peer
Description

Supplies bioreactor systems, single-use technologies, and process development tools across the bioprocess workflow. Competes head-on with AUXO V® in scalable bioreactor hardware, particularly for customers moving from process development to manufacturing.

TypeBroad incumbent
Description

Diversified life sciences incumbent offering bioreactor systems (e.g., HyPerforma) as part of a much broader portfolio spanning instruments, consumables, and services. A potential competitor and potential acquirer as it extends into food-grade bioprocessing.

6Applikon Biotechnology (Getinge)
TypeDirect peer
Description

Specialist bioreactor manufacturer (now part of Getinge) with benchtop, pilot, and production-scale systems for life sciences and food applications. Direct peer across the full AUXO V® product range.

7Culture Biosciences
TypeEmerging player
Description

Cloud-based bioprocess development platform offering remote-operated bioreactor access and data analytics. Adjacent emerging player that combines bioreactor access with software — a model relevant to n!Biomachines' NVIDIA-enabled smart-manufacturing roadmap.

TypeBroad incumbent
Description

Horizontal platform for cell programming and biomanufacturing, with growing infrastructure for cultivated meat and precision fermentation customers. A potential partner or competitor in cellular agriculture bioprocess development.

TypeDirect peer
Description

Designs and manufactures stirred-tank bioreactors and fermenters for industrial biotechnology, with strength in food, beverage, and industrial biotech. Closely comparable on fit-for-purpose positioning for non-pharma bioprocess applications.

TypeDirect peer
Description

Manufacturer of benchtop and pilot-scale bioreactors (e.g., BioFlo series) used in academic and industrial bioprocessing. Direct competitor in laboratory and pilot-scale bioreactor segments, with overlap in academic and startup customer segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

n!Biomachines

Bioprocessing Equipmentthecultivatedb.ca

n!Biomachines Ltd., a subsidiary of The Cultivated B GmbH, develops and manufactures fit-for-purpose AUXO V® bioreactors spanning benchtop to industrial scale (up to 25,000L) for the food, supplement, and cosmetics industries, alongside supporting automation and real-time monitoring software.

What n!Biomachines does

n!Biomachines Ltd. is a Burlington, Ontario-based biotechnology company—wholly owned by German parent The Cultivated B GmbH—that develops and manufactures fit-for-purpose bioreactors under the AUXO V® brand for next-generation bioprocessing. Founded in 2021 and operating with 11–50 employees, the company targets the food, supplement, and cosmetics industries rather than pharmaceutical applications, positioning its hardware as a lower-cost, purpose-built alternative to incumbent pharma-grade systems.

Its product portfolio spans three scale tiers—AUXO V® Benchtop, Pilot-Scale, and Industrial-Scale bioreactors (up to 25,000L)—supported by dedicated software for advanced automation and real-time on-site and remote monitoring. Core differentiators include fit-for-purpose engineering for specific biological processes and host organisms (cell, microbial, algae), modular cultivation design, and a design philosophy that strips 'superfluous features' to reduce capital and operating costs. The AUXO V bioreactor earned a 2024 Red Dot Design Award.

Commercially, n!Biomachines runs a dual go-to-market: a sales-led motion targeting enterprise and industrial buyers through website CTAs ('Configure your biomachine', 'Meet an expert') with multi-year contracts on industrial-scale systems, alongside a product-led/self-service channel for benchtop and pilot customers. Revenue comes from bioreactor hardware sales, customization/configuration, and support services. Recent strategic activity—MOUs with the Weizmann Institute of Science (Nov 2025) and Lambton College (May 2025), and entry into the NVIDIA Connect Program (2025)—signals ecosystem-building around scientific validation and AI-enabled bioprocessing, though no financial scale signals (revenue, funding, headcount growth) are disclosed.

n!Biomachines firmographics

Firmographics
Name
n!Biomachines
Legal name
n!Biomachines Ltd.
Website
https://thecultivatedb.ca
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
n!Biomachines Ltd., a subsidiary of The Cultivated B GmbH, develops and manufactures fit-for-purpose AUXO V® bioreactors spanning benchtop to industrial scale (up to 25,000L) for the food, supplement, and cosmetics industries, alongside supporting automation and real-time monitoring software.
Ownership category
akta.pro rank

n!Biomachines industry classification

Industry
Product category
Bioprocessing Equipment
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Industrial Instruments For Measurement, Display, And Control (3823)
akta.pro industry
PRIMARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Bioreactor manufacturing
  • Bioprocessing equipment
  • Cellular agriculture systems
  • Precision fermentation bioreactors
  • Industrial-scale bioprocessing

Where n!Biomachines is headquartered

Location

Headquarters

HQ city
Burlington
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

n!Biomachines business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Bioreactor Hardware Sales: Sale of fit-for-purpose bioreactor systems across benchtop, pilot-scale, and industrial-scale configurations. Hardware includes AUXO V® bioreactors tailored to specific biological processes and customer requirements.
  2. Support & Services: Technical support, maintenance, and services for bioreactor systems including Bioengineering hub services.
  3. Customization & Configuration: Tailored bioreactor solutions engineered to meet specific customer requirements for different types of bioprocesses or host organisms.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractIndustrial-scale bioreactors for large-scale production

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

n!Biomachines product offering

Product offering

Core offering

n!Biomachines develops and manufactures fit-for-purpose AUXO V® bioreactor systems for next-generation bioprocessing, available in benchtop, pilot-scale, and industrial-scale configurations up to 25,000 liters. The company provides proprietary software for advanced automation and real-time monitoring, along with support services and a bioengineering hub, targeting the food, supplement, and cosmetics industries with affordable, scalable, and modular solutions tailored to specific biological processes and host organisms.

Product overview

n!Biomachines is a subsidiary of The Cultivated B that develops and manufactures fit-for-purpose bioreactors under the AUXO V® brand. The product portfolio consists of three core bioreactor lines—Benchtop, Pilot-Scale, and Industrial-Scale—along with supporting software solutions. The AUXO V® bioreactors are designed for specific biological processes and organisms, targeting the food, supplement, and cosmetics industries. The bioreactors offer scalability from laboratory scale up to 25,000L, with features including modularity for different cultivation types (cell, microbial, algae), advanced automation, real-time monitoring, and a focus on affordability and sustainability.

Differentiator

Problem solved

Functional benefit

Brands

  • AUXO V®: Fit-for-purpose bioreactor product line designed and engineered to meet specific requirements of biological processes for different cell types, hosts, and products. Available in benchtop, pilot-scale, and industrial-scale configurations.

Products and services

  • AUXO V® Benchtop Bioreactors

Quantifiable outcome

  • Scalable production from benchtop to industrial scale up to 25,000L

Companies that use n!Biomachines

Customer profile

Segments4 records

Ideal customer profiles4 records

n!Biomachines technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

n!Biomachines partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and flagship.

  • Weizmann Institute of SciencecoreStrategic or Co-development Partner · 3 November 2025Entered a Memorandum of Understanding (MOU) to validate and advance the functionality of n!Biomachines' next-generation bioreactor systems. The partnership focuses on scientific validation of bioreactor technology for bioprocessing applications.
  • Lambton CollegecoreStrategic or Co-development Partner · 21 May 2025Signed MOU to advance cellular agriculture innovation in Canada. Partnership marks beginning of collaborative effort to advance the field of cellular agriculture, with n!Biomachines providing bioreactor technology and expertise.
  • NVIDIA (NVIDIA Connect Program)flagshipTechnology or Integration · 1 April 2025n!Biomachines joined the NVIDIA Connect Program as part of their mission to enable smarter biomanufacturing. The partnership represents a significant step forward in AI-enabled bioprocessing capabilities.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

n!Biomachines competitors and assessment

Company assessment

Direct peers

  • Sartorius AG: Global leader in bioprocess solutions, including bioreactors for cell culture and microbial fermentation. Directly competes with n!Biomachines in bioprocess equipment, though Sartorius is heavily focused on pharmaceutical applications where n!Biomachines' fit-for-purpose food-grade positioning differentiates.
  • PBS Biotech: Specializes in single-use bioreactors for cell therapy, regenerative medicine, and cell culture applications. Direct peer in scalable single-use bioreactor hardware, with comparable modularity and customization features.
  • ABEC Inc. Custom-engineered bioreactor and fermentation systems provider serving cell therapy, vaccines, and biotech manufacturing. Direct peer in custom large-scale bioreactor engineering, with growing overlap in cellular agriculture and food-grade bioprocessing.
  • Cytiva (Danaher): Supplies bioreactor systems, single-use technologies, and process development tools across the bioprocess workflow. Competes head-on with AUXO V® in scalable bioreactor hardware, particularly for customers moving from process development to manufacturing.
  • Applikon Biotechnology (Getinge): Specialist bioreactor manufacturer (now part of Getinge) with benchtop, pilot, and production-scale systems for life sciences and food applications. Direct peer across the full AUXO V® product range.
  • Solaris Biotech (Donaldson Company): Designs and manufactures stirred-tank bioreactors and fermenters for industrial biotechnology, with strength in food, beverage, and industrial biotech. Closely comparable on fit-for-purpose positioning for non-pharma bioprocess applications.
  • Eppendorf AG: Manufacturer of benchtop and pilot-scale bioreactors (e.g., BioFlo series) used in academic and industrial bioprocessing. Direct competitor in laboratory and pilot-scale bioreactor segments, with overlap in academic and startup customer segments.

Broad incumbents

  • Thermo Fisher Scientific: Diversified life sciences incumbent offering bioreactor systems (e.g., HyPerforma) as part of a much broader portfolio spanning instruments, consumables, and services. A potential competitor and potential acquirer as it extends into food-grade bioprocessing.
  • Ginkgo Bioworks: Horizontal platform for cell programming and biomanufacturing, with growing infrastructure for cultivated meat and precision fermentation customers. A potential partner or competitor in cellular agriculture bioprocess development.

Emerging players

  • Culture Biosciences: Cloud-based bioprocess development platform offering remote-operated bioreactor access and data analytics. Adjacent emerging player that combines bioreactor access with software — a model relevant to n!Biomachines' NVIDIA-enabled smart-manufacturing roadmap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

n!Biomachines social profiles

Digital presence

n!Biomachines financial estimates

Financial estimate

Revenue estimate

Valuation estimate

n!Biomachines leadership team

Management profile

Number of profiles

n!Biomachines funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

n!Biomachines M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about n!Biomachines

What does n!Biomachines do?

n!Biomachines develops and manufactures fit-for-purpose AUXO V® bioreactor systems for next-generation bioprocessing, available in benchtop, pilot-scale, and industrial-scale configurations up to 25,000 liters. The company provides proprietary software for advanced automation and real-time monitoring, along with support services and a bioengineering hub, targeting the food, supplement, and cosmetics industries with affordable, scalable, and modular solutions tailored to specific biological processes and host organisms.

Is n!Biomachines a public or private company?

n!Biomachines is a private company. It is classified as corporate owned and is currently operating.

When was n!Biomachines founded?

n!Biomachines was founded in 2013. It employs 11 to 50 people.

Where is n!Biomachines based?

n!Biomachines is headquartered in Burlington, Canada, in the North America region.

How does n!Biomachines make money?

Three revenue lines are on record. Bioreactor Hardware Sales are the primary driver. The others are support & Services and customization & Configuration.

Who are n!Biomachines's main competitors?

Direct peers on record are Sartorius AG, PBS Biotech, ABEC Inc., Cytiva (Danaher), Applikon Biotechnology (Getinge), Solaris Biotech (Donaldson Company) and Eppendorf AG. Broad incumbents are Thermo Fisher Scientific and Ginkgo Bioworks. Culture Biosciences is listed as an emerging player.

Does n!Biomachines have an API?

No public API is recorded for n!Biomachines.

What industry is n!Biomachines in?

n!Biomachines's product category is Bioprocessing Equipment. Its primary akta.pro industry code is HLAAAJAA, Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 334516 and its SIC code is 3823.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals